成都欣捷高新技术开发股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
26
NMPA:26
Drug Approvals
Diprophylline Injection
- Product Name
- 二羟丙茶碱注射液
- Approval Number
- 国药准字H20254515
- Approval Date
- Jun 10, 2025
NMPA
Composite Potassium Hydrogen Phosphate Injection
- Product Name
- 复合磷酸氢钾注射液
- Approval Number
- 国药准字H20254092
- Approval Date
- May 13, 2025
NMPA
Epinephrine Hydrochloride Injection
- Product Name
- 盐酸肾上腺素注射液
- Approval Number
- 国药准字H20253602
- Approval Date
- Mar 11, 2025
NMPA
Potassium Chloride Injection
- Product Name
- 氯化钾注射液
- Approval Number
- 国药准字H20249480
- Approval Date
- Dec 1, 2024
NMPA
Pamidronate Disodium Injection
- Product Name
- 帕米膦酸二钠注射液
- Approval Number
- 国药准字H20244922
- Approval Date
- Sep 19, 2024
NMPA
Bromhexine Hydrochloride Tablets
- Product Name
- 盐酸溴己新片
- Approval Number
- 国药准字H20244820
- Approval Date
- Sep 3, 2024
NMPA
Isoprenaline Hydrochloride Injection
- Product Name
- 盐酸异丙肾上腺素注射液
- Approval Number
- 国药准字H20244012
- Approval Date
- Jun 11, 2024
NMPA
Isoprenaline Hydrochloride Injection
- Product Name
- 盐酸异丙肾上腺素注射液
- Approval Number
- 国药准字H20244011
- Approval Date
- Jun 11, 2024
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found